Tango Therapeutics Inc TNGX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
7.79UNCH (UNCH)
Volume
20,350
Close
7.79quote price arrow down-0.01 (-0.13%)
Volume
374,866
52 week range
2.47 - 13.03
Loading...
  • Open7.82
  • Day High7.96
  • Day Low7.76
  • Prev Close7.80
  • 52 Week High13.03
  • 52 Week High Date10/05/23
  • 52 Week Low2.47
  • 52 Week Low Date05/31/23

Key Stats

  • Market Cap831.469M
  • Shares Out106.74M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-21.31

KEY STATS

  • Open7.82
  • Day High7.96
  • Day Low7.76
  • Prev Close7.80
  • 52 Week High13.03
  • 52 Week High Date10/05/23
  • 52 Week Low2.47
  • 52 Week Low Date05/31/23
  • Market Cap831.469M
  • Shares Out106.74M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-21.31

RATIOS/PROFITABILITY

  • EPS (TTM)-1.11
  • P/E (TTM)-7.03
  • Fwd P/E (NTM)-5.49
  • EBITDA (TTM)-123.716M
  • ROE (TTM)-45.41%
  • Revenue (TTM)37.232M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-299.88%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tango Therapeutics Inc

 

Profile

MORE
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of...
Alexis Borisy
Independent Chairman of the Board
Barbara Weber M.D.
President, Chief Executive Officer, Director
Daniella Beckman CPA
Chief Financial Officer
Address
201 Brookline Avenue, Suite 901
Boston, MA
02215
United States

Top Peers

SYMBOLLASTCHG%CHG
RLAY
Relay Therapeutics Inc
6.51-0.29-4.19%
ZNTL
Zentalis Pharmaceuticals Inc
11.96-0.01-0.13%
CVAC
CureVac NV
3.48+0.29+9.09%
ANAB
AnaptysBio Inc
25.47-0.13-0.51%
IRON
Disc Medicine Inc
31.92+0.06+0.19%